Q4 2024 Management View Barry Biffle, CEO, highlighted the company's adjusted pre-tax margin of 5.1%, exceeding original guidance, supported by revenue and network optimization initiatives, and cost ...
We recently published a list of 12 Best Automation Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Teradyne, Inc. (NASDAQ:TER) stands against other best ...
Q4 2024 Management View Willie Chiang, Chairman and CEO, highlighted that the company exceeded expectations for both Q4 and the full year, reporting adjusted EBITDA attributable to Plains of $729 ...
2h
Hosted on MSNCrypto Currents: MicroStrategy changes name, reports Q4 resultsAs bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust ...
Amazon’s lackluster outlook for FY25 and as-expected growth in its cloud services business may have spooked investors, but Wall Street analysts see the 4% drop in the share price as a buying ...
Q4 2024 Management View CEO Deanna Strable highlighted achieving 2024 EPS growth of 11%, within the guided range of 9% to 12%, and a 16% year-over-year EPS increase in Q4. The company's ROE improved ...
Holdings Inc. (NASDAQ: ULOG) reported its fourth-quarter 2024 earnings, revealing a mixed performance that led to an after-hours stock decline. The company's earnings per share (EPS) fell short of ...
Green Plains (NASDAQ:GPRE) -15.6% in Friday's trading to its lowest in nearly five years after posting a much larger than expected Q4 GAAP loss and launching a corporate reorganization and cost ...
4h
24/7 Wall St. on MSNMicroStrategy Rebrands, but It Is the Same Risky InvestmentBecause of its cryptocurrency hoarding strategy, MicroStrategy (NASDAQ:MSTR) is now a big deal. It needs a new name to go along with its plus-sized game plan, so it has rebranded as Strategy. It is ...
Byrna Technologies Inc. reported robust financial results for the fourth quarter of 2024, surpassing revenue expectations with a 79% year-over-year increase to $28 million. The company's performance, ...
Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.
Amazon (AMZN) stock is pulling back, after a better-than-expected fourth quarter was overshadowed by a weak forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results